HDFCBANK - HDFC Bank Limited
NSE
->
Financial Services
->
Banks—Regional
Mumbai,
India
Type: Equity
HDFCBANK price evolution
HDFCBANK
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1047228.6 | $1015406.1 | $1553857.3 | $1574053.5 |
| Short term investments | $447380.8 | |||
| Net receivables | $157494.3 | $137547 | ||
| Inventory | $512.2 | |||
| Total current assets | $1047228.6 | $1172900.4 | $1553857.3 | $1711600.5 |
| Long term investments | $5124931.8 | $4900162 | $4492638.6 | $4154187.9 |
| Property, plant & equipment | $68280.3 | $65041.6 | $62832.8 | $56547.8 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $22835773.9 | $21648584.4 | $21229343 | $19902703.6 |
| Current liabilities | ||||
| Accounts payable | $16708598.2 | $16036290.5 | $15580030.3 | $14442041 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $16708598.2 | $16036290.5 | $15580030.3 | $14442041 |
| Long term debt | $2517432.9 | $2169461.4 | $2269665 | $2324725.7 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $20204751.7 | $19061882.4 | $18748877.2 | $17531370.7 |
| Shareholders' equity | ||||
| Retained earnings | $1724726.1 | |||
| Other shareholder equity | $2617593.1 | $2573660.3 | $2467716.2 | $2358886.3 |
| Total shareholder equity | $2623163.1 | $2579214.9 | $2473261.7 | $2364428.7 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1553857.3 | $346243.54 | $249426.89 | $424455.14 |
| Short term investments | $447380.8 | $93203.7 | $91968.6 | $108322.5 |
| Net receivables | ||||
| Inventory | $512.2 | $512.56 | ||
| Total current assets | $1553857.3 | $1460639.89 | $1101258.12 | $1039308.37 |
| Long term investments | $4492638.6 | $4388456.12 | $3893049.52 | $2894604.92 |
| Property, plant & equipment | $62832.8 | $50995.63 | $46268.56 | $42198.37 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $21229343 | $17995066.44 | $15808304.37 | $12928057.06 |
| Current liabilities | ||||
| Accounts payable | $15580030.3 | $13337208.76 | $11462071.34 | $9225026.78 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $15580030.3 | $13988945.71 | $12148976.09 | $9551908.58 |
| Long term debt | $2269665 | $1330708.29 | $1343101.23 | $1403327.79 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $18748877.2 | $15890636.91 | $14038950.91 | $11386312.53 |
| Shareholders' equity | ||||
| Retained earnings | $1724726.1 | $1388635.12 | $1110956.52 | $927301.23 |
| Other shareholder equity | $2467716.2 | $98827.16 | $59591.92 | $34873.57 |
| Total shareholder equity | $2473261.7 | $2098101.89 | $1763587.05 | $1536726.59 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $271061.9 | $241783.8 | $247033.7 | $248252.4 |
| Cost of revenue | ||||
| Gross Profit | $271061.9 | $241783.8 | $247033.7 | $248252.4 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $46317.5 | $46068.6 | $42006.3 | $41212.3 |
| Total operating expenses | $121497.9 | $113550.8 | $110135.2 | $106071.1 |
| Operating income | $149564 | $128233 | $136898.5 | $142181.3 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $37938.1 | $32066.3 | $32149.6 | $36023.6 |
| Interest expense | ||||
| Net income | ||||
| Net income | $111252.1 | $95791.1 | $104430.1 | $105914.6 |
| Income (for common shares) | $111252.1 | $95791.1 | $104430.1 | $105914.6 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $911858.2 | $777974.05 | $712309.11 | $620129.23 |
| Cost of revenue | ||||
| Gross Profit | $911858.2 | $777974.05 | $712309.11 | $620129.23 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $158970.3 | $214970.02 | $196864.64 | $168591.22 |
| Total operating expenses | $403124.3 | $350012.57 | $330360.55 | $276947.6 |
| Operating income | $508733.9 | $427961.48 | $381948.55 | $343181.63 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $127224.9 | $109393.8 | $108985.9 | $118725.5 |
| Interest expense | ||||
| Net income | ||||
| Net income | $380527.5 | $318332.09 | $272539.51 | $223324.31 |
| Income (for common shares) | $380527.5 | $318332.09 | $272539.51 | $223324.31 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $111252.1 | $95791.1 | $104430.1 | $105914.6 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Net income | $380527.5 | $318332.09 | $272539.51 | $223324.31 |
| Operating activities | ||||
| Depreciation | $16807.3 | $13850.06 | $12767.71 | $12206.67 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$2362417.2 | -$1450372.86 | -$2405735.48 | -$1969990.81 |
| Investing activities | ||||
| Capital expenditures | -$22362.4 | -$16961.46 | -$16358.71 | -$16206.12 |
| Investments | ||||
| Total cash flows from investing | -$22163.3 | -$16808.65 | -$16169.24 | -$15984.09 |
| Financing activities | ||||
| Dividends paid | -$35924 | -$49836.26 | -$40958.93 | |
| Sale and purchase of stock | ||||
| Net borrowings | $489708.3 | -$91375.74 | $291015.44 | $12906.94 |
| Total cash flows from financing | $2724061.7 | $1801923.91 | $2480989.53 | $1572582.29 |
| Effect of exchange rate | $1651 | -$1418.25 | $2139.89 | $953.46 |
| Change in cash and equivalents | $341132.2 | $333324.15 | $61224.7 | -$412439.14 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $1.01T |
|---|---|
| EBITDA | N/A |
| EBIT | $0.00 |
| Net Income | $417.39B |
| Revenue Q/Q | 21.51% |
| Revenue Y/Y | 20.41% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 1.95% |
| ROE | 16.63% |
| Debt/Equity | 7.58 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.06 |
| Quick ratio | N/A |